December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

177.36 +0.47 (+0.27%)
Streaming Delayed Price Updated: 11:32 AM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
1 Healthcare Stock Worth Investigating and 2 That Underwhelm
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
1 Momentum Stock to Target This Week and 2 Facing Headwinds
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos... 
Via StockStory
News headline image
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition ↗
Masimo develops advanced noninvasive monitoring technologies used by hospitals and healthcare providers worldwide. 
Via The Motley Fool
News headline image
3 Overrated Stocks We Steer Clear Of
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
Topics Firearms
News headline image
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗
This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitorin... 
Via StockStory
Topics Artificial Intelligence
News headline image
The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal
As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise.... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
1 Cash-Producing Stock on Our Buy List and 2 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
1 Oversold Stock Set for a Comeback and 2 Facing Challenges
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
Topics Artificial Intelligence
News headline image
Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow
Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings this Thursday after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring
In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Naya Capital Adds Masimo Shares ↗
Masimo supplies noninvasive monitoring tech to hospitals and care providers, serving both medical and consumer health markets worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Reasons MASI is Risky and 1 Stock to Buy Instead
Masimo’s 19% return over the past six months has outpaced the S&P 500 by 12.2%, and its stock price has climbed to $174.61 per share. This was partly due to its solid quarterly results, and the run-up... 
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Reasons MASI is Risky and 1 Stock to Buy Instead
Masimo has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.4%. The stock now trades at $174.58, marking a 13.4% gain. This was partly due to its solid... 
Via StockStory
Topics Stocks Supply Chain
News headline image
Danaher's $9.9 Billion Bet: Masimo Acquisition to Redefine the Diagnostics Landscape
In a move that signals a massive consolidation in the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to... 
Via MarketMinute
Topics Artificial Intelligence Economy
Top movers analysis one hour before the close of the markets on 2026-02-17: top gainers and losers in today's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot
As of February 17, 2026, Danaher Corporation (NYSE: DHR) finds itself at a pivotal juncture in its multi-decade evolution. Once the darling of the "compounding" investment community, the Washington,... 
Via Finterra
Topics Artificial Intelligence Earnings Supply Chain
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Danaher Deal Finalized: Company To Acquire Masimo For $9.9 Billion In Cash ↗
The deal will entail Danaher paying $180 per share for Masimo, reflecting about 18 times Masimo’s projected 2027 earnings before interest, taxes, depreciation, and amortization. 
Via Stocktwits
News headline image
Masimo Heads For $10B Buyout After Winning Blood Oxygen Patent Case Against Apple ↗
Danaher is reportedly set to acquire Masimo, with the deal expected to be announced as early as Tuesday. 
Via Stocktwits
Topics Intellectual Property
News headline image
3 of Wall Street’s Favorite Stocks That Concern Us
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
News headline image
The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare
The convergence of consumer technology and clinical medicine has reached a fever pitch as 2025 draws to a close. A landmark report released this December by ResearchAndMarkets.com projects that the... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
1 Healthcare Stock to Research Further and 2 That Underwhelm
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have... 
Via StockStory
Topics Stocks
News headline image
Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Masimo (NASDAQ:MASI) and the best and worst... 
Via StockStory
Topics Artificial Intelligence
News headline image
Masimo (MASI) Stock Is Up, What You Need To Know
Shares of medical tech company Masimo (NASDAQ:MASI) jumped 3.5% in the morning session after the company presented an upbeat long-term financial outlook at its 2025 Investor Day, prompting positive... 
Via StockStory
Topics Artificial Intelligence Economy Supply Chain
News headline image
Masimo (MASI) Q3 2025 Earnings Call Transcript ↗
Masimo (MASI) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
1 Volatile Stock to Target This Week and 2 We Ignore
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
News headline image
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.